Published in Drug Law Weekly, December 5th, 2006
"IDPN is costly and restricted by Medicare and other payers. Oral supplementation (PO) is a more promising,...
Want to see the full article?
Welcome to NewsRx!
Learn more about a six-week, no-risk free trial of Drug Law Weekly
Source: Drug Law Weekly (2006-12-05)
NewsRx also is available at LexisNexis, Gale, ProQuest, Factiva, Dialog, Thomson Reuters, NewsEdge, and Dow Jones.